Published in J Hepatol on April 01, 2001
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol (2009) 2.22
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. BMC Cancer (2008) 1.37
Characteristics of common solid liver lesions and recommendations for diagnostic workup. World J Gastroenterol (2009) 1.32
The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer (2007) 1.17
N-linked glycosylation of the liver cancer biomarker GP73. J Cell Biochem (2008) 1.14
Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis. Br J Cancer (2008) 1.11
Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma. Hepatol Int (2010) 1.10
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer (2009) 1.08
Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol (2008) 1.06
Liver cancer: Approaching a personalized care. J Hepatol (2015) 1.05
Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients. Ups J Med Sci (2010) 1.04
Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma. Cytojournal (2005) 0.99
Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it? World J Gastroenterol (2013) 0.96
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection--results from a clinic-based longitudinal cohort. Eur J Cancer (2012) 0.94
Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci (2010) 0.94
Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C. Hepatol Int (2009) 0.92
Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma. PLoS One (2013) 0.91
Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. Transplantation (2009) 0.90
Assessment of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma in Middle Eastern patients. Dig Dis Sci (2010) 0.88
Hepatocellular carcinoma (HCC) with portal vein invasion, masquerading as pancreatic mass, diagnosed by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). Dig Dis Sci (2007) 0.87
Preclinical and post-treatment changes in the HCC-associated serum proteome. Br J Cancer (2006) 0.86
Impaired autophagy response in human hepatocellular carcinoma. Exp Mol Pathol (2013) 0.84
Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients. Mol Cell Proteomics (2013) 0.83
The value of serum midkine level in diagnosis of hepatocellular carcinoma. Int J Hepatol (2015) 0.83
Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China. Int J Clin Exp Med (2015) 0.83
Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis. Diagn Pathol (2013) 0.82
Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. World J Hepatol (2009) 0.81
Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine. EPMA J (2014) 0.80
Hepatocellular carcinoma - issues in imaging. Cancer Imaging (2004) 0.79
Prevention and Management of Chronic Hepatitis B. Int J Prev Med (2014) 0.79
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus. Hepat Med (2011) 0.78
Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis. J Hematol Oncol (2012) 0.77
Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization. Int J Clin Oncol (2013) 0.76
Surrogate markers of efficacy for medical treatment of viral hepatitis. Biotechnol Healthc (2004) 0.75
Whither α-FP in the diagnosis of hepatocellular carcinoma? J Hepatocell Carcinoma (2015) 0.75
Socioeconomic disparities in access to a hepatocellular carcinoma screening program in Brazil. Clinics (Sao Paulo) (2016) 0.75
Approach to Solid Liver Masses in the Cirrhotic Patient. Gastroenterology Res (2009) 0.75
Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria. World J Hepatol (2016) 0.75
Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver Cirrhosis. Visc Med (2016) 0.75
Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions. Chin J Cancer Res (2013) 0.75
Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012. Int J Circumpolar Health (2016) 0.75
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut (2001) 4.12
Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med (2000) 3.97
Calmodulin target database. J Struct Funct Genomics (2000) 3.20
Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst (1999) 2.98
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut (2000) 2.55
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci (1999) 2.13
The conduct of orthopaedic clinical trials. J Bone Joint Surg Am (1997) 1.96
Screening for hepatocellular carcinoma. Hepatology (1998) 1.78
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res (1996) 1.67
Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut (2002) 1.66
Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am J Gastroenterol (1997) 1.61
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis (2010) 1.52
Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science (1985) 1.51
Chronic reactive airway disease following acute chlorine gas exposure in an asymptomatic atopic patient. Chest (1991) 1.51
Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum (1990) 1.50
Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect (1998) 1.46
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3. J Viral Hepat (2008) 1.45
Hostility predicts restenosis after percutaneous transluminal coronary angioplasty. Mayo Clin Proc (1996) 1.42
Rapid degradation of an abnormal protein in Escherichia coli involves the chaperones GroEL and GroES. J Biol Chem (1994) 1.41
AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) (2003) 1.39
Trigger factor is involved in GroEL-dependent protein degradation in Escherichia coli and promotes binding of GroEL to unfolded proteins. EMBO J (1995) 1.34
Alpha-fetoprotein in antenatal diagnosis of congenital nephrosis. Lancet (1975) 1.34
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection. Hepatology (2001) 1.32
Genome-scale phylogeny of the alphavirus genus suggests a marine origin. J Virol (2011) 1.23
Posttranscriptional stabilization of c-fms mRNA by a labile protein during human monocytic differentiation. Mol Cell Biol (1989) 1.16
Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med (1995) 1.14
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer (2012) 1.13
Trigger factor associates with GroEL in vivo and promotes its binding to certain polypeptides. J Biol Chem (1997) 1.13
Immunization of HLA-A2+ melanoma patients with MAGE-3 or MelanA peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12. Clin Cancer Res (2001) 1.09
Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program. Am J Public Health (1998) 1.08
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice. Aliment Pharmacol Ther (2006) 1.07
Therapeutic index of nutritional depletion in hospitalized patients. Surg Gynecol Obstet (1975) 1.06
Rapid degradation of an abnormal protein in Escherichia coli proceeds through repeated cycles of association with GroEL. J Biol Chem (1999) 1.05
Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers. Hepatology (1985) 1.05
Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int (1996) 1.00
The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology (1997) 1.00
Atrial infarction: diagnosis and management. Am Heart J (1988) 0.99
Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. Clin Oncol (R Coll Radiol) (2006) 0.98
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome. J Clin Oncol (1993) 0.97
Group B streptococcal lung infection in neonatal rabbits. Pediatr Res (1982) 0.97
Molecular basis for the constitutive activity of estrogen-related receptor alpha-1. J Biol Chem (2001) 0.97
Downregulation of c-fms gene expression in human monocytes treated with phorbol esters and colony-stimulating factor 1. Blood (1989) 0.97
Spatial associations among density of cattle, abundance of wild canids, and seroprevalence to Neospora caninum in a population of beef calves. J Am Vet Med Assoc (2000) 0.97
Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy. Ann Intern Med (1990) 0.94
Penetration and metabolism of DDT in resistant and susceptible house flies and the effect on latent toxicity. J Econ Entomol (1966) 0.93
Some permutation tests for survival data. Biometrics (1996) 0.93
A new system for catheter ablation of atrial fibrillation. Am J Cardiol (1999) 0.93
Respiratory muscle dysfunction in hereditary motor sensory neuropathy, type I. Arch Intern Med (1988) 0.92
Rapid identification of patient specimens with microsatellite DNA markers. Mod Pathol (1996) 0.92
Improved precision with Hologic Apex software. Osteoporos Int (2008) 0.91
Dacryoscopy. Ophthalmic Surg (1979) 0.91
Mental illness and the ipact of believing others know about it. J Abnorm Psychol (1971) 0.91
Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling. Mol Pharmacol (1999) 0.91
Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B. Am J Pathol (1992) 0.91
Radioimmunoassay of human ligandin. Hepatology (1983) 0.91
Neonatal lung defense mechanisms: a study of the alveolar macrophage system in neonatal rabbits. Am Rev Respir Dis (1977) 0.91
Cellular immunity in adult marasmus. Arch Intern Med (1977) 0.91
Glutathione S-transferase in human hepatocellular carcinoma. Hepatology (1983) 0.90
Attachment in autism and other developmental disorders. J Am Acad Child Adolesc Psychiatry (1987) 0.89
The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines. Bioorg Med Chem Lett (2001) 0.88
Self-ratings of graduating family practice residents' psychological medicine abilities. Fam Pract Res J (1988) 0.87
Tissue-specific activity of heterologous viral promoters in primary rat hepatocytes and Hep G2 cells. Hepatology (1989) 0.87
Maternal representation of the self as parent: connections with maternal sensitivity and maternal structuring. Attach Hum Dev (2000) 0.86
Nitrogen metabolism and insulin requirements in obese diabetic adults on a protein-sparing modified fast. Diabetes (1976) 0.86
Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol Psychiatry (1997) 0.86
Effect of a protein-sparing diet and brief fast on nitrogen metabolism in mildly obese subjects. J Lab Clin Med (1977) 0.85
Retinal X- and Y-cells in monocularly lid-sutured cats: normality of spatial and temporal properties. Brain Res (1979) 0.84
Thalassemic children's understanding of illness: a study of cognitive and emotional factors. Ann N Y Acad Sci (1985) 0.84
Extra-articular augmentation for residual hip dysplasia. Radiological assessment after Chiari osteotomies and shelf procedures. J Bone Joint Surg Br (1993) 0.83
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirin. Aliment Pharmacol Ther (2008) 0.83
Perioperative psychosocial interventions for autistic children undergoing ENT surgery. Int J Pediatr Otorhinolaryngol (1997) 0.82
The v-raf oncogene enhances tumorigenicity and suppresses differentiation in vivo in a rat hepatocyte cell line. Carcinogenesis (1993) 0.82
Results of the treatment of obesity with a protein-sparing modified fast. Int J Obes (1978) 0.82
Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: efficacy and safety. Cardiovasc Intervent Radiol (2007) 0.82
Sequence of human tryptophan 2,3-dioxygenase (TDO2): presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. Genomics (1995) 0.82
Treasured objects in school-aged children. Pediatrics (1981) 0.82
Pilot study of interferon-alpha and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values. J Viral Hepat (2001) 0.81
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy. Can J Gastroenterol (2009) 0.81
Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation. J Cell Physiol (1986) 0.81
Glutathione S-transferase in human organs. Biochem Int (1983) 0.81
Communicating: a practical guide for the liaison psychiatrist. Psychiatr Clin North Am (1982) 0.81
Methionine oxidation within the cerebroside-sulfate activator protein (CSAct or Saposin B). Protein Sci (2000) 0.81
Development and evaluation of a system of microencapsulation of primary rat hepatocytes. Hepatology (1989) 0.81
Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3. Aliment Pharmacol Ther (2011) 0.80
Requirement for Akt-mediated survival in cell transformation by the dbl oncogene. Cell Signal (2006) 0.80
The mechanisms of nitrogen sparing in fasting supplemented by protein and carbohydrate. J Clin Endocrinol Metab (1981) 0.80
Extrapulmonary Pneumocystis carinii in a patient with AIDS: sonographic findings. AJR Am J Roentgenol (1990) 0.80
Inorganic pyrophosphate gives a membrane potential in yeast mitochondria, as measured with the permeant cation tetraphenylphosphonium. Arch Biochem Biophys (1993) 0.80
Pneumomediastinum induced by inhalation of alkaloidal cocaine. N Y State J Med (1988) 0.79
Hepatitis A virus seroprevalence in 1,000 university students in Toronto. Can Commun Dis Rep (2001) 0.79
Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Ann Intern Med (2001) 0.79
Ganglions of the foot: a six-year retrospective study and a review of the literature. J Am Podiatry Assoc (1980) 0.79
San Diego Suicide Study: the adolescents. Adolescence (1990) 0.78
ras transformation of simian virus 40-immortalized rat hepatocytes: an in vitro model of hepatocarcinogenesis. Cancer Res (1992) 0.78